Press Releases

The NWHN’s statement on the FDA’s Announcement of the Review of Harmful Restriction on Medication Abortion

By NWHN Staff | May 8, 2021 | Comments Off on The NWHN’s statement on the FDA’s Announcement of the Review of Harmful Restriction on Medication Abortion

The following statement can be attributed to Cynthia A. Pearson, Executive Director of the National Women’s Health Network. Contact: Evita Almassi, ealmassi@nwhn.org or 425-749-1886 The FDA announced that it is reviewing its restrictions on mifepristone, a medication used for miscarriage…

The National Women’s Health Network calls on Johnson & Johnson and other manufacturers to give women full information about all of their products, not just the COVID-19 vaccine

By M. Isabelle Chaudry | Apr 28, 2021 | Comments Off on The National Women’s Health Network calls on Johnson & Johnson and other manufacturers to give women full information about all of their products, not just the COVID-19 vaccine

In light of the recent decision by the U.S. government to resume using Johnson & Johnson vaccines in the race to protect vulnerable people from COVID-19, we are struck by the disparity between publicly disclosed information about the J&J vaccine…

The NWHN’s Statement on the Guilty Verdict of Former Minneapolis Police Officer Derek Chauvin

By Evita Almassi | Apr 20, 2021 | Comments Off on The NWHN’s Statement on the Guilty Verdict of Former Minneapolis Police Officer Derek Chauvin

Washington D.C. — As a national women’s health organization, we know that health justice demands racial justice. Being protected against racially motivated police violence is a health issue. This guilty on all counts verdict today is only one small step…

The NWHN’s Statement on the FDA Lifting Unnecessary Restrictions on Medication Abortion

By NWHN Staff | Apr 13, 2021 | Comments Off on The NWHN’s Statement on the FDA Lifting Unnecessary Restrictions on Medication Abortion

Late last night, the FDA announced that, effective immediately, both medication abortion and miscarriage patients would be able to access mifepristone via delivery from their providers or through mail-order pharmacies. This tremendous victory will ensure that patients and providers are protected during the pandemic.

The NWHN’s Statement in Support of the Asian American Pacific Islander Community

By NWHN Staff | Mar 18, 2021 | Comments Off on The NWHN’s Statement in Support of the Asian American Pacific Islander Community

We at the National Women’s Health Network are deeply concerned for the safety of our community members across the country as violence toward Asian Americans has escalated over the past year. We have said before and we will say it again. Health justice demands racial justice.

Cynthia A. Pearson steps down as Executive Director of the National Women’s Health Network

By Evita Almassi | Feb 22, 2021 | Comments Off on Cynthia A. Pearson steps down as Executive Director of the National Women’s Health Network

After more than twenty years, Cindy Pearson announced today she is stepping down as Executive Director of the National Women’s Health Network.

The Biden-Harris Administration’s Executive Actions on Sexual and Reproductive Health, Rights and Justice are a Good First Step but more must be done.

By Evita Almassi | Jan 28, 2021 | Comments Off on The Biden-Harris Administration’s Executive Actions on Sexual and Reproductive Health, Rights and Justice are a Good First Step but more must be done.

For Immediate Release

The NWHN’s statement on The Supreme Court’s Decision to Revive the Abortion Pill Restriction

By Cindy Pearson | Jan 13, 2021 | Comments Off on The NWHN’s statement on The Supreme Court’s Decision to Revive the Abortion Pill Restriction

Last night, the U.S. Supreme Court reinstated the U. S. Food and Drug Administration’s medically unjustified requirement that people travel to a certified facility simply to pick up abortion pills that they are then allowed to safely take at home.

The NWHN’s statement in response to the FDA’s vaccine advisory committee’s vote to recommend emergency use authorization of the COVID-19 vaccine developed by Pfizer/BioNTech

By NWHN Staff | Dec 11, 2020 | Comments Off on The NWHN’s statement in response to the FDA’s vaccine advisory committee’s vote to recommend emergency use authorization of the COVID-19 vaccine developed by Pfizer/BioNTech

The NWHN ultimately applauds the FDA Advisory Committee’s decision, but believes that transparency now and going forward is key. We urge the FDA to keep the public informed about the vaccine’s safety, efficacy, and side effects as it is distributed at scale. Further, we urge other vaccine sponsors seeking authorization to submit robust data for all deeply impacted populations. Read our full statement here.

The NWHN’s statement in response to the House Appropriations Committee’s historic hearing on the Hyde Amendment

By NWHN Staff | Dec 8, 2020 | Comments Off on The NWHN’s statement in response to the House Appropriations Committee’s historic hearing on the Hyde Amendment

December 8, 2020 FOR IMMEDIATE RELEASE Contact: Adele Costa, acosta@nwhn.org The NWHN commends U.S. Representative Rosa DeLauro, All Above All, and the formidable advocates for reproductive health care that participated in the virtual hearing on the harms of the Hyde…